Citrate Anticoagulation System For Extracorporeal Blood Treatments

Patent No. EP2324871 (titled "Citrate Anticoagulation System For Extracorporeal Blood Treatments") was filed by Baxter on Nov 22, 2006. The application was issued on May 26, 2021.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
B BRAUN AVITUMMar 21, 2017WINTER
FRESENIUS MEDICAL CAREMar 21, 2017HERRMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2324871

BAXTER
Application Number
EP11153847A
Filing Date
Nov 22, 2006
Status
Patent Maintained As Amended
Apr 23, 2021
Publication Date
May 26, 2021